In CRC patients, preoperative CEA level is an important indicator for predicting recurrence and survival, and an elevation in postoperative CEA level is associated with adverse clinical features, including intestinal obstruction, perforation, advanced tumor stage, and the presence of lymphatic, vascular, or perineural invasion (34). The gene discussed is CEACAM5; the disease is colorectal carcinoma.